NCT05847387

Brief Summary

The purpose of this international cohort study is to validate a new method for preoperative assessment of endothelial viability in donor corneal tissues for transplantation, and to correlate endothelial health as assessed by the surgical team to functional and structural long-term outcomes in the cohort of patients receiving them.

Trial Health

83
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
135

participants targeted

Target at P50-P75 for all trials

Timeline
4mo left

Started Dec 2023

Typical duration for all trials

Geographic Reach
6 countries

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Dec 2023Sep 2026

First Submitted

Initial submission to the registry

April 27, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Expected
Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

2.3 years

First QC Date

April 27, 2023

Last Update Submit

September 29, 2025

Conditions

Keywords

KeratoplastyCorneal endotheliumEye Banking

Outcome Measures

Primary Outcomes (1)

  • Trypan Blue Positive Areas (TBPA) percentage and Donor mortality

    The comparison of the endothelial mortality of included donor corneas measured preoperatively (TBPA) and the overall endothelial mortality as declared by the eye bank providing the tissue

    Preoperative

Secondary Outcomes (6)

  • Correlation of TBPA to declared endothelial cell density (dECD)

    Preoperative

  • Correlation of TBPA to declared endothelial mortality on corneal folds

    Preoperative

  • Final ECD

    1 year after enrollment

  • Rate of endothelial cell loss

    1 year after enrollment

  • Incidence of endothelial graft failure

    1 year after enrollment

  • +1 more secondary outcomes

Study Arms (1)

Keratoplasty group

Patients undergoing keratoplasty and their respective donor tissue

Diagnostic Test: V-Check

Interventions

V-CheckDIAGNOSTIC_TEST

Preoperative analysis of endothelial tissue staining with vital dye (Trypan Blue 0.05%) and image analysis to identify the percentage of Trypan Blue Positive Areas, corresponding to dead endothelial cells and/or denuded areas of endothelium, in tissues destined to keratoplasty

Keratoplasty group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Consecutive patients undergoing keratoplasty at participating referral cornea clinics

You may qualify if:

  • Age older than 18 years old
  • Planned corneal transplantation: perforating keratoplasty (PK), Descemet stripping automated endothelial keratoplasty (DSAEK), ultra-thin DSAEK (UT-DSAEK) or Descemet membrane endothelial keratoplasty (DMEK)
  • Indication for corneal transplantation (low-moderate risk of rejection): keratoconus, Fuchs endothelial dystrophy
  • Ability to provide written informed consent.

You may not qualify if:

  • Prior corneal transplantation
  • Planned preloaded DSAEK or preloaded DMEK
  • Planned keratoplasty not involving corneal endothelium transplantation (i.e., superficial/deep anterior lamellar keratoplasty)
  • Evidence of concurrent microbial keratitis
  • Evidence of non-infectious or autoimmune keratitis
  • Impending or frank corneal perforation
  • Uncontrolled, elevated intraocular pressure (IOP)- Previous glaucoma surgery
  • Acute or chronic inflammatory/infectious anterior segment uveitis
  • Presence of an anterior chamber intraocular lens (IOL) for phakic or aphakic purposes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Antwerp University Hospital

Edegem, 2650, Belgium

NOT YET RECRUITING

Department of Ophthalmology, University of Cologne

Cologne, 50937, Germany

NOT YET RECRUITING

Münster University Hospital

Münster, 48149, Germany

NOT YET RECRUITING

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Brescia, BS, 25123, Italy

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

NOT YET RECRUITING

Department of Medical and Surgical Sciences, University Magna Græcia

Catanzaro, 88100, Italy

NOT YET RECRUITING

Department of Experimental Medicine, Tor Vergata School of Medicine and Surgery

Roma, 00133, Italy

NOT YET RECRUITING

Fondazione Banca degli Occhi del Veneto

Venice, 30174, Italy

NOT YET RECRUITING

San Bortolo Hospital

Vicenza, 36100, Italy

NOT YET RECRUITING

Maastricht University Medical Center

Maastricht, 6229, Netherlands

NOT YET RECRUITING

Hospital Regional Universitario de Málaga

Málaga, 29010, Spain

NOT YET RECRUITING

Royal Liverpool University Hospital

Liverpool, L7 8YE, United Kingdom

NOT YET RECRUITING

Related Publications (1)

  • Airaldi M, Zheng Y, Aiello F, Bachmann B, Baydoun L, Ni Dhubhghaill S, Dickman MM, Kaye SB, Fontana L, Gadhvi KA, Moramarco A, Rodriguez Calvo de Mora M, Rocha de Lossada C, Scorcia V, Viola P, Calza S, Levis HJ, Parekh M, Ruzza A, Ferrari S, Ponzin D, Semeraro F, Romano V. Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol. BMJ Open Ophthalmol. 2023 Sep;8(1):e001361. doi: 10.1136/bmjophth-2023-001361.

MeSH Terms

Conditions

Corneal Endothelial Cell Loss

Condition Hierarchy (Ancestors)

Corneal DiseasesEye DiseasesEye ManifestationsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Vito Romano, MD

    Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Matteo Airaldi, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 27, 2023

First Posted

May 6, 2023

Study Start

December 1, 2023

Primary Completion

March 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

All collected IPD with appropriated anonymization of sensible data will be stored to a dedicated repository after completion of the study

Shared Documents
STUDY PROTOCOL
Time Frame
After completion of study
Access Criteria
Upon approval of individual sharing request

Locations